# A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®

> **NCT00877136** · — · COMPLETED · sponsor: **St. Joseph Hospital of Orange** · enrollment: 18 (actual)

## Conditions studied

- Liver Tumors
- Hepatocellular Carcinoma
- Hepatoma
- Neoplasms

## Interventions

- **DEVICE:** TheraSphere®

## Key facts

- **NCT ID:** NCT00877136
- **Lead sponsor:** St. Joseph Hospital of Orange
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2015-02
- **Final completion:** 2021-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00877136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00877136, "A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00877136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*